Transthoracic echocardiographic abnormalities in asymptomatic diabetic patients: Association with microalbuminuria and silent coronary artery disease

被引:20
作者
Nguyen, M. T. [3 ,4 ]
Cosson, E. [3 ,4 ]
Valensi, P. [3 ]
Poignard, P. [1 ]
Nitenberg, A. [1 ]
Pham, I. [1 ,2 ]
机构
[1] Hop Jean Verdier, AP HP, Serv Explorat Fonct, Bondy, France
[2] Univ Paris 13, UFR SMBH, EA 23 63, Bobigny, France
[3] Univ Paris 13, CRNH IdF, Jean Verdier Hosp, AP HP,Dept Endocrinol Diabetol Nutr, Bondy, France
[4] Univ Paris 13, UMR Inserm U557, Inra U1125, Bondy, France
关键词
Diabetes mellitus; Type; 1; diabetes; 2; Transthoracic echocardiography; Left ventricular function; Silent coronary artery disease; Silent myocardial ischaemia; Microalbuminuria; LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-ISCHEMIA; DYSFUNCTION; RECOMMENDATIONS; EPIDEMIOLOGY; HYPERTENSION; MORTALITY; STENOSES; MELLITUS; EVENTS;
D O I
10.1016/j.diabet.2010.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims. - This study aimed to assess, on routine echocardiography, cardiac left ventricular (LV) disorders, their determinants and their role in the screening process of silent myocardial ischaemia (SMI) in asymptomatic diabetic patients. Methods. - A total of 586 asymptomatic diabetic patients with one or more additional cardiovascular risk factors, but no history of heart failure or myocardial infarction, prospectively underwent rest echocardiography and myocardial scintigraphy. Those with SMI (abnormal scintigraphy) were subsequently screened for angiographic coronary artery disease (CAD). Results. - LV hypertrophy, LV dilatation, systolic dysfunction and hypokinesia were found in 33.6, 8.6, 3.2 and 6.1%, respectively, of the study population. SMI was found in 156 (26.6%) patients, 55 of whom had silent CAD. On multivariate analysis, age (OR: 1.03 [1.00-1.05], P = 0.02), microalbuminuria (OR: 2.2 [1.4-3.2], P < 0.0001) and silent CAD (OR: 2.4 [1.3-4.6], P = 0.007) were predictive of LV hypertrophy. Creatinine clearance (OR: 0.97 [0.96-0.99], P = 0.002) and silent CAD (OR: 3.7 [1.3-10.0]) were associated with LV dilatation. LV systolic dysfunction was associated with microalbuminuria (OR: 3.8 [1.3-11.4], P = 0.02) and silent CAD (OR: 3.8 [1.1-12.6], P = 0.03). Hypokinesia was associated with retinopathy (OR: 2.4 [1.1-5.4], P = 0.04), microalbuminuria (OR: 2.3 [1.1-5.0], P = 0.04) and LV dilatation (OR: 3.0 [1.1-8.1], P = 0.03). In patients with SMI, the positive predictive value of LV hypertrophy associated with another echocardiographic abnormality (n = 19) for CAD was 63.2%. Conclusion. - LV hypertrophy was found in one-third of asymptomatic diabetic patients, while LV dilatation, systolic dysfunction or hypokinesia was seen in <10%. The main predictors of LV abnormalities were microalbuminuria and silent CAD. The presence of LV hypertrophy with another abnormality should raise the possibility of the presence of silent CAD. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 50 条
  • [21] Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients
    Pham, Isabelle
    Cosson, Emmanuel
    Nguyen, Minh Tuan
    Banu, Isabela
    Genevois, Isabelle
    Poignard, Patricia
    Valensi, Paul
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [22] Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease
    Gyldenkerne, Christine
    Olesen, Kevin Kris Warnakula
    Madsen, Morten
    Thim, Troels
    Jensen, Lisette Okkels
    Raungaard, Bent
    Sorensen, Henrik Toft
    Botker, Hans Erik
    Maeng, Michael
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (04) : 351 - 359
  • [23] Coronary artery disease among asymptomatic diabetic and nondiabetic patients undergoing coronary computed tomography angiography
    Zeina, Abdel-Rauf
    Odeh, Majed
    Rosenschein, Uri
    Zaid, Ghassan
    Barmeir, Elisha
    CORONARY ARTERY DISEASE, 2008, 19 (01) : 37 - 41
  • [24] Association of microalbuminuria and fasting insulin levels with presence and severity of coronary artery disease in non-diabetic cases
    Ekicibasi, Erkan
    Kaderli, Aysel Aydin
    Kazazoglu, Ali Riza
    Ozdemir, Buelent
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2008, 8 (01) : 16 - 21
  • [25] Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease
    Tsujimoto, Tetsuro
    Kajio, Hiroshi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 282 : 1 - 6
  • [26] The relation between microalbuminuria and coronary collateral vessel development in patients with unstable coronary artery disease
    Topsakal, Ramazan
    Kaya, Mehmet G.
    Duran, Mustafa
    Gunebakmaz, Ozgur
    Dogan, Ali
    Inanc, Tugrul
    Yarlioglues, Mikail
    Celik, Ahmet
    Ergin, Ali
    CORONARY ARTERY DISEASE, 2009, 20 (07) : 431 - 434
  • [27] Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
    Valensi, Paul
    Avignon, Antoine
    Sultan, Ariane
    Chanu, Bernard
    Minh Tuan Nguyen
    Cosson, Emmanuel
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [28] Does microalbuminuria in diabetic patients affect the postoperative course after coronary artery bypass surgery?
    Yorgancioglu, C
    Tokmakoglu, H
    Suzer, K
    Zorlutuna, Y
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (03) : 395 - 400
  • [29] Silent coronary artery disease in patients with diabetes mellitus
    Zellweger, MJ
    Pfisterer, ME
    SWISS MEDICAL WEEKLY, 2001, 131 (29-30) : 427 - 432
  • [30] Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients
    Carmine Gazzaruso
    Adriana Coppola
    Tiziana Montalcini
    Cinzia Valenti
    Gabriele Pelissero
    Sebastiano Bruno Solerte
    Fabrizio Salvucci
    Pietro Gallotti
    Arturo Pujia
    Adriana Garzaniti
    Andrea Giustina
    Internal and Emergency Medicine, 2012, 7 : 257 - 266